Constantijn E. V. B. Hazenberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Constantijn E. V. B. Hazenberg has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Joost A. van Herwaarden
Department of Vascular Surgery, University Medical Center Utrecht, the Netherlands
8 shared publications - Martin Teraa
Department of Vascular Surgery, University Medical Center Utrecht, the Netherlands
7 shared publications - Gert Jan de Borst
Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, the Netherlands
4 shared publications Joost A. van Herwaarden
3 shared publications- Santi Trimarchi
University of Milan
3 shared publications - Sicco A. Bus
Department of Rehabilitation Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
3 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by SAGE Publications in Journal of Endovascular Therapy
Early Experience of Fiber Optic RealShape Technology in Endovascular Interventions for Peripheral Artery Disease: A Prospective Single-Center Study
Objective: Interventions in peripheral artery disease (PAD) have changed significantly over the past decades. Most centers have adopted an endovascular-first strategy resulting in an increased radiation exposure, especially for the treatment team. Fiber Optic RealShape (FORS) technology uses laser light instead of fluoroscopy to visualize the specially designed guidewire and catheters. The aim of this early experience overview was to evaluate feasibility and safety of FORS-guided navigation for endovascular interventions in PAD. Methods: This overview presents prospectively collected, single-center data of FORS-guided PAD interventions. Feasibility was evaluated through technical success in crossing stenotic lesion(s) or occlusion(s). Lesion characteristics were also recorded. Safety was assessed by scoring of intraoperative adverse events related to FORS. Secondary assessments included navigation time, and radiation exposure outcomes (cumulative air kerma [CAK], air kerma-area product [KAP], and fluoroscopy time [FT]) during crossing of the culprit lesion. Results: In 22 patients (31 lesions) selected for FORS-guided PAD interventions, 22 of 31 lesions (71.0%) were successfully crossed while using FORS-enabled devices, without adverse events. Median length of the treated lesions was 48.0 mm (23.0-87.0). Sixteen lesions (51.6%) had a severe degree of stenosis and 10 lesions (32.3%) had a moderate degree of stenosis, defined according to the North American Symptomatic Carotid Endarterectomy Trial criteria. Navigation times, CAK, and FT were highest during FORS-guided interventions of most complex stenotic lesions. Conclusion: Fiber Optic RealShape-guided navigation and lesion crossing in PAD interventions is feasible and safe. Expansion of the FORS portfolio hypothetically in combination with other radiation-reducing technologies might enable a radiation-free interventional environment in the future. Clinical Impact: Fiber Optic RealShape (FORS) represents a novel technology that enables visualization of specially designed endovascular devices by utilizing laser light instead of fluoroscopy. These devices facilitate real-time visualization with three-dimensional features to simplify endovascular navigation without the necessity of using fluoroscopy during navigation. This is the first single-center study that presents an overview of 31 peripheral arterial disease (PAD) lesions (in 22 patients) showing that using FORS guided navigation in PAD interventions is safe and feasible. Ultimately, the use of FORS in combination with other radiation reducing technologies might eventually enable a radiation-free interventional environment in the future.
- 26 October 2026
- Published by SAGE Publications in Journal of Endovascular Therapy
Open AccessEarly Experience of Fiber Optic RealShape Technology in Endovascular Interventions for Peripheral Artery Disease: A Prospective Single-Center Study
Objective: Interventions in peripheral artery disease (PAD) have changed significantly over the past decades. Most centers have adopted an endovascular-first strategy resulting in an increased radiation exposure, especially for the treatment team. Fiber Optic RealShape (FORS) technology uses laser light instead of fluoroscopy to visualize the specially designed guidewire and catheters. The aim of this early experience overview was to evaluate feasibility and safety of FORS-guided navigation for endovascular interventions in PAD. Methods: This overview presents prospectively collected, single-center data of FORS-guided PAD interventions. Feasibility was evaluated through technical success in crossing stenotic lesion(s) or occlusion(s). Lesion characteristics were also recorded. Safety was assessed by scoring of intraoperative adverse events related to FORS. Secondary assessments included navigation time, and radiation exposure outcomes (cumulative air kerma [CAK], air kerma-area product [KAP], and fluoroscopy time [FT]) during crossing of the culprit lesion. Results: In 22 patients (31 lesions) selected for FORS-guided PAD interventions, 22 of 31 lesions (71.0%) were successfully crossed while using FORS-enabled devices, without adverse events. Median length of the treated lesions was 48.0 mm (23.0-87.0). Sixteen lesions (51.6%) had a severe degree of stenosis and 10 lesions (32.3%) had a moderate degree of stenosis, defined according to the North American Symptomatic Carotid Endarterectomy Trial criteria. Navigation times, CAK, and FT were highest during FORS-guided interventions of most complex stenotic lesions. Conclusion: Fiber Optic RealShape-guided navigation and lesion crossing in PAD interventions is feasible and safe. Expansion of the FORS portfolio hypothetically in combination with other radiation-reducing technologies might enable a radiation-free interventional environment in the future. Clinical Impact: Fiber Optic RealShape (FORS) represents a novel technology that enables visualization of specially designed endovascular devices by utilizing laser light instead of fluoroscopy. These devices facilitate real-time visualization with three-dimensional features to simplify endovascular navigation without the necessity of using fluoroscopy during navigation. This is the first single-center study that presents an overview of 31 peripheral arterial disease (PAD) lesions (in 22 patients) showing that using FORS guided navigation in PAD interventions is safe and feasible. Ultimately, the use of FORS in combination with other radiation reducing technologies might eventually enable a radiation-free interventional environment in the future.
- Open Access
- 1 July 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (5) , 1212-1222.e2
Procedural outcomes and follow-up of endovascular treatment for extracranial carotid artery aneurysms; a systematic review
- 1 July 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (5) , 1212-1222.e2
Open AccessProcedural outcomes and follow-up of endovascular treatment for extracranial carotid artery aneurysms; a systematic review
- Open Access
- 11 June 2026
- Published by SAGE Publications in Vascular Medicine
- Vol. 31 (4) , 562-564
Peripheral artery disease in pseudoxanthoma elasticum: Walking capacity on the 6-minute walking test
- 11 June 2026
- Published by SAGE Publications in Vascular Medicine
- Vol. 31 (4) , 562-564
Open AccessPeripheral artery disease in pseudoxanthoma elasticum: Walking capacity on the 6-minute walking test
- Open Access
- 15 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1532
Impact of Endovascular Aortic Repair on Aortic Stiffness: Preliminary Results from a Prospective In Vivo Study Following EVAR
Background: Aortic stiffness (AoS) is an established predictor of cardiovascular morbidity and mortality. Endovascular aneurysm repair (EVAR) introduces a rigid stent-graft into the aorta, potentially increasing AoS and impairing subendocardial perfusion. This prospective study aimed to evaluate changes in AoS and myocardial perfusion following EVAR, measured by carotid-to-femoral pulse wave velocity (cf-PWV) and the Subendocardial Viability Ratio (SEVR), and examined the influence of graft length on post-operative cf-PWV and SEVR. Methods: From October 2023 to April 2025, 38 patients undergoing elective EVAR were prospectively enrolled. Cf-PWV and the SEVR were measured ® device. Descriptive statistics were used to summarize baseline characteristics. Data were assessed for normality with the Shapiro–Wilk test; non-normally distributed variables were analysed using the Wilcoxon signed-rank test and presented as median [interquartile range, IQR], while normally distributed variables were analysed using paired t-tests and presented as mean ± standard deviation (SD). Linear regression was applied to evaluate associations between graft length and postoperative changes in cf-PWV and SEVR. Results: Cf-PWV increased significantly after EVAR, with a median within-patient change of 1.0 m/s [IQR 3.1] (p < 0.001), corresponding to a 10.6% increase. The SEVR decreased significantly by 15.1% (p = 0.006). Graft length correlated positively with cf-PWV change, with a 0.2% increase in cf-PWV per millimetre of graft length (r = 0.41; p = 0.029), but not with SEVR (r = 0.058, p = 0.763). Conclusions: EVAR was associated with increased AoS and reduced subendocardial perfusion, with greater stiffness changes observed in patients receiving longer grafts. These preliminary findings highlight important haemodynamic consequences of EVAR and may inform patient selection, postoperative management, and the development of future stent-graft designs to mitigate long-term cardiovascular risk.
- 15 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1532
Open AccessImpact of Endovascular Aortic Repair on Aortic Stiffness: Preliminary Results from a Prospective In Vivo Study Following EVAR
Background: Aortic stiffness (AoS) is an established predictor of cardiovascular morbidity and mortality. Endovascular aneurysm repair (EVAR) introduces a rigid stent-graft into the aorta, potentially increasing AoS and impairing subendocardial perfusion. This prospective study aimed to evaluate changes in AoS and myocardial perfusion following EVAR, measured by carotid-to-femoral pulse wave velocity (cf-PWV) and the Subendocardial Viability Ratio (SEVR), and examined the influence of graft length on post-operative cf-PWV and SEVR. Methods: From October 2023 to April 2025, 38 patients undergoing elective EVAR were prospectively enrolled. Cf-PWV and the SEVR were measured ® device. Descriptive statistics were used to summarize baseline characteristics. Data were assessed for normality with the Shapiro–Wilk test; non-normally distributed variables were analysed using the Wilcoxon signed-rank test and presented as median [interquartile range, IQR], while normally distributed variables were analysed using paired t-tests and presented as mean ± standard deviation (SD). Linear regression was applied to evaluate associations between graft length and postoperative changes in cf-PWV and SEVR. Results: Cf-PWV increased significantly after EVAR, with a median within-patient change of 1.0 m/s [IQR 3.1] (p < 0.001), corresponding to a 10.6% increase. The SEVR decreased significantly by 15.1% (p = 0.006). Graft length correlated positively with cf-PWV change, with a 0.2% increase in cf-PWV per millimetre of graft length (r = 0.41; p = 0.029), but not with SEVR (r = 0.058, p = 0.763). Conclusions: EVAR was associated with increased AoS and reduced subendocardial perfusion, with greater stiffness changes observed in patients receiving longer grafts. These preliminary findings highlight important haemodynamic consequences of EVAR and may inform patient selection, postoperative management, and the development of future stent-graft designs to mitigate long-term cardiovascular risk.
- Open Access
- 22 December 2025
- Published by MDPI AG in Biomedicines
- Vol. 14 (1) , 28
The Current State of Mock Circulatory Loop Applications in Aortic and Cardiovascular Research: A Scoping Review
Background: Mock circulatory loops (MCLs) are benchtop experimental platforms that reproduce key features of the human cardiovascular system, providing a safe, controlled, and reproducible environment for haemodynamic investigation. This scoping review aims to systematically map the current landscape of MCLs used for aortic simulation and identify major areas of application. Methods: A systematic search of PubMed, Scopus, and Web of Science identified original studies employing MCLs for aortic simulation. Eligible studies were categorized into predefined themes: (I) (bio)mechanical aortic characterization, (II) hemodynamics, (III) device testing, (IV) diagnostics, and (V) training. Data on MCL configurations, aortic models, and study objectives were synthesized narratively. Results: Eighty-four studies met the inclusion criteria. Twenty-five investigated aortic biomechanics, 23 hemodynamics, 22 device or product testing, 13 validated diagnostic imaging techniques, and one training application. Models included porcine (n = 22), human cadaveric (n = 7), canine (n = 1), ovine (n = 1), bovine (n = 1), and 3D-printed or molded aortic phantoms (n = 55). MCLs were employed to study parameters such as aortic stiffness, flow dynamics, dissection propagation, endoleaks, imaging accuracy, and device performance. Conclusions: This review provides a comprehensive overview of MCL applications in aortic research. MCLs represent a versatile pre-clinical platform for studying aortic pathophysiology and testing endovascular therapies under controlled conditions. Standardized reporting frameworks are now required to improve reproducibility and accelerate translation to patient-specific planning.
- 22 December 2025
- Published by MDPI AG in Biomedicines
- Vol. 14 (1) , 28
Open AccessThe Current State of Mock Circulatory Loop Applications in Aortic and Cardiovascular Research: A Scoping Review
Background: Mock circulatory loops (MCLs) are benchtop experimental platforms that reproduce key features of the human cardiovascular system, providing a safe, controlled, and reproducible environment for haemodynamic investigation. This scoping review aims to systematically map the current landscape of MCLs used for aortic simulation and identify major areas of application. Methods: A systematic search of PubMed, Scopus, and Web of Science identified original studies employing MCLs for aortic simulation. Eligible studies were categorized into predefined themes: (I) (bio)mechanical aortic characterization, (II) hemodynamics, (III) device testing, (IV) diagnostics, and (V) training. Data on MCL configurations, aortic models, and study objectives were synthesized narratively. Results: Eighty-four studies met the inclusion criteria. Twenty-five investigated aortic biomechanics, 23 hemodynamics, 22 device or product testing, 13 validated diagnostic imaging techniques, and one training application. Models included porcine (n = 22), human cadaveric (n = 7), canine (n = 1), ovine (n = 1), bovine (n = 1), and 3D-printed or molded aortic phantoms (n = 55). MCLs were employed to study parameters such as aortic stiffness, flow dynamics, dissection propagation, endoleaks, imaging accuracy, and device performance. Conclusions: This review provides a comprehensive overview of MCL applications in aortic research. MCLs represent a versatile pre-clinical platform for studying aortic pathophysiology and testing endovascular therapies under controlled conditions. Standardized reporting frameworks are now required to improve reproducibility and accelerate translation to patient-specific planning.
- 15 October 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (4) , 999-1009.e2
The effect of aneurysm diameter on perioperative outcomes following endovascular thoracoabdominal aortic aneurysm repair
- 15 October 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (4) , 999-1009.e2
The effect of aneurysm diameter on perioperative outcomes following endovascular thoracoabdominal aortic aneurysm repair
- Open Access
- 20 June 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (4) , 492-499
First in Human Use of Non-invasive, Robot Assisted, High Intensity Focused Ultrasound Treatment of Femoral Atherosclerosis: A Safety and Feasibility Pilot Study
- 20 June 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (4) , 492-499
Open AccessFirst in Human Use of Non-invasive, Robot Assisted, High Intensity Focused Ultrasound Treatment of Femoral Atherosclerosis: A Safety and Feasibility Pilot Study